MDxHealth S.A.
MXDHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | 0.06 | 0.20 | 0.05 |
| FCF Yield | -1.83% | -7.89% | -17.93% | -12.58% |
| EV / EBITDA | 226.16 | -20.95 | -11.14 | -7.42 |
| Quality | ||||
| ROIC | -3.59% | -9.40% | -15.92% | -9.73% |
| Gross Margin | 66.03% | 61.99% | 60.36% | 65.10% |
| Cash Conversion Ratio | 0.42 | 0.82 | 0.70 | 1.07 |
| Growth | ||||
| Revenue 3-Year CAGR | 82.18% | 74.33% | 60.64% | 38.71% |
| Free Cash Flow Growth | 78.54% | 20.87% | 14.58% | -4.06% |
| Safety | ||||
| Net Debt / EBITDA | 73.14 | -2.15 | -3.94 | -1.11 |
| Interest Coverage | -0.30 | -1.50 | -3.01 | -1.04 |
| Efficiency | ||||
| Inventory Turnover | 4.94 | 4.72 | 4.43 | 4.87 |
| Cash Conversion Cycle | 11.24 | 6.85 | -16.44 | -13.96 |